Post by Next Steps in Derm

NEW THERAPEUTIC CHEAT SHEET! Looking to master the ins and outs of the newly approved biologic for moderate-to-severe atopic dermatitis? We’ve got you covered! Introducing our June Therapeutic Cheat Sheet on Lebrikizumab (Ebglyss®) This comprehensive guide breaks down everything you need to know to optimize patient care: 🧬 Mechanism of Action: How it selectively targets IL-13 while sparing natural clearance. 📈 Dosing Schedules: Loading vs. maintenance intervals for adult and pediatric patients (≥12 years, ≥40 kg). 👁️ Safety & Monitoring: Managing common side effects like conjunctivitis and navigating baseline monitoring. 📚 Off-Label & Combination Uses: A sneak peek into emerging real-world data, including dual therapy with JAK inhibitors. A huge thank you to GW Dermatology Resident Dr. Dillon Nussbaum for compiling this invaluable clinical resource! Headed to the clinic? Save this post for quick access or head to the link below to download the full, printer-friendly PDF! https://lnkd.in/gABg6C9v #Dermatology #NextStepsInDerm #Lebrikizumab #Ebglyss #AtopicDermatitis #EczemaTreatment #ResidentEducation #DermResidency #TherapeuticCheatSheet #MedicalDermatology #Biologics #DermTwitter #GWMed